Fadlo R. Khuri
Fadlo R. Khuri
President and Professor, American University of Beirut
aub.edu.lb üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
16872015
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
16522018
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
15562014
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri, J Nemunaitis, I Ganly, J Arseneau, IF Tannock, L Romel, ...
Nature medicine 6 (8), 879-885, 2000
13402000
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ...
Jama 311 (19), 1998-2006, 2014
13242014
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
12012018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
11102018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
9982018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
9722018
The BATTLE trial: personalizing therapy for lung cancer
ES Kim, RS Herbst, II Wistuba, JJ Lee, GR Blumenschein, A Tsao, ...
Cancer discovery 1 (1), 44-53, 2011
8932011
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun, LM Rosenberg, X Wang, Z Zhou, P Yue, H Fu, FR Khuri
Cancer research 65 (16), 7052-7058, 2005
8822005
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
SG Swisher, JA Roth, J Nemunaitis, DD Lawrence, BL Kemp, ...
Journal of the National Cancer Institute 91 (9), 763-771, 1999
855*1999
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth
T Hitosugi, S Kang, MG Vander Heiden, TW Chung, S Elf, K Lythgoe, ...
Science signaling 2 (97), ra73-ra73, 2009
7022009
Integrated genomic characterization of oesophageal carcinoma
Cancer Genome Atlas Research Network
Nature 541 (7636), 169, 2017
6962017
Perspectives for cancer prevention with natural compounds
ARMR Amin, O Kucuk, FR Khuri, DM Shin
Journal of clinical oncology 27 (16), 2712, 2009
6042009
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
J Nemunaitis, F Khuri, I Ganly, J Arseneau, M Posner, E Vokes, J Kuhn, ...
Journal of Clinical Oncology 19 (2), 289-298, 2001
5922001
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck …
R Haddad, A O'Neill, G Rabinowits, R Tishler, F Khuri, D Adkins, J Clark, ...
The lancet oncology 14 (3), 257-264, 2013
5862013
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
FR Khuri, H Wu, JJ Lee, BL Kemp, R Lotan, SM Lippman, L Feng, ...
Clinical Cancer Research 7 (4), 861-867, 2001
5692001
Clonal genetic alterations in the lungs of current and former smokers
L Mao, JS Lee, JM Kurie, YH Fan, SM Lippman, A Broxson, FR Khuri, ...
Journal of the National Cancer Institute 89 (12), 857-862, 1997
5391997
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial
J Nemunaitis, I Ganly, F Khuri, J Arseneau, J Kuhn, T McCarty, S Landers, ...
Cancer research 60 (22), 6359-6366, 2000
5232000
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20